| sumatriptan succinate / Generic mfg. |
NCT00356603: Study Of Sumatriptan Succinate Injection Kit In Patients With Migraine or Cluster Headache In Japan |
|
|
| Completed | 3 | 75 | Japan | Sumatriptan Succinate | GlaxoSmithKline | Migraine Disorders | 08/06 | 08/06 | | |
NCT00510419: A Study to Assess an Auto-injector Being Used to Treat a Migraine Attack |
|
|
| Completed | 3 | 73 | US | "Investigational"Auto-injector (sumatriptan succinate) | Pfizer | Migraine | 12/07 | 12/07 | | |
| Completed | 3 | 530 | US | NP101 - Sumatriptan iontophoretic transdermal patch, Sumatriptan, Placebo, NP101 Placebo | NuPathe Inc. | Migraine Disorders | 07/09 | 07/09 | | |
|
|
|
NP101-008, NCT00792103: An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months |
|
|
| Completed | 3 | 198 | US | NP101 | NuPathe Inc. | Migraine Disorders | 09/10 | 09/10 | | |
NCT00963937: Study to Evaluate the Efficacy and Safety of Oral Sumatriptan for the Acute Treatment of Migraine in Children and Adolescents |
|
|
| Completed | 3 | 178 | Japan | Sumatriptan 25 mg, Sumatriptan 50 mg, Placebo | GlaxoSmithKline | Migraine Disorders | 12/10 | 12/10 | | |
|
NP101-009, NCT00806546: An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months |
|
|
| Completed | 3 | 514 | US | NP101 | NuPathe Inc. | Migraine Disorders | 05/11 | 05/11 | | |
NCT01462812: Safety & Efficacy of a Single Dose of Sumatriptan Powder Delivered Intranasally With the Bi-directional Device in Adults With Acute Migraine |
|
|
| Completed | 3 | 223 | US | Sumatriptan, Placebo | Optinose US Inc. | Migraine Headache | 06/12 | 06/12 | | |
|
|
|
COMPASS, NCT01667679: Efficacy and Safety of 20 mg Sumatriptan Powder Delivered Intranasally With the Bi-directional Device Compared With 100 mg Sumatriptan Tablets in Adults With Acute Migraine With or Without Aura |
|
|
| Completed | 3 | 275 | US | 100 mg Sumatriptan Tablet and OPTINOSE Placebo delivered nasally, OPTINOSE SUMATRIPTAN delivered nasally and placebo tablet | Avanir Pharmaceuticals | Migraine, Headaches | 03/14 | 06/14 | | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
